The Theophylline Extended-Release Ca, cataloged under National Stock Number 6505-01-173-1906, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Aventis Pharmaceuticals Products Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-173-1906 |
| Primary Part Number | NDC00075-0200-99 |
| Item Name | Theophylline Extended-Release Ca |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Aventis Pharmaceuticals Products Inc. |
| Status | ACTIVE |
| Therapeutic Equivalent | SLO-BID GYROCAPS BY RORER PHARMACEUTICAL |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 1000.000 |
| Active Medicament Medicinal Strength | 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00075-0200-99 PRIMARY | Aventis Pharmaceuticals Products Inc. (USA) |
| NDC00258-3634-01 | Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc (USA) |
| Reference | Meaning |
|---|---|
| SLO-BID GYROCAPS | 5/1 Secondary reference Aventis Pharmaceuticals Products Inc. |
| NDC00258-3634-01 | 3/1 Design control — primary reference Inwood Laboratories Inc |
| SLO-BID | 5/1 Secondary reference Aventis Pharmaceuticals Products Inc. |
| NDC00603-5951-21 | 3/1 Design control — primary reference Generics Bidco I, Llc Dba Par Pharmaceutical |
NSN 6505-01-173-1906 is a Theophylline Extended-Release Ca, manufactured by Aventis Pharmaceuticals Products Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-173-1906 has 2 manufacturer part numbers on file: NDC00075-0200-99 (Aventis Pharmaceuticals Products Inc.), NDC00258-3634-01 (Forest Pharmaceuticals Inc Sub of Forest Laboratories Inc).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-318-9418. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00075-0200-99: Therapeutic Equivalent: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: ANHYDROUS. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.